Is Archit Organosys overvalued or undervalued?

As of 17 October 2025, Archit Organosys has moved from a fair to an attractive valuation grade. The company is currently considered overvalued based on its high PE ratio of 154.30, an EV to EBIT of 107.77, and a PEG ratio of 0.02, which suggests that despite the attractive grade, the stock may not be a good buy at this price level.
In comparison to peers, Solar Industries has a PE of 100.67 and an EV to EBITDA of 61.95, while Godrej Industries shows a more reasonable PE of 36.08 and an EV to EBITDA of 29.02. Archit Organosys's high valuation metrics, particularly its PE ratio, indicate that the market may be pricing in excessive growth expectations. While the stock has seen a significant return over the past five years at 217.16%, its recent performance has lagged behind the Sensex, particularly over the past three years, where it has declined by 46.78% compared to the Sensex's gain of 43.73%.